Pharmacists are being encouraged to refer patients to a new Type 1 diabetes trial
Type 1 Diabetes in children is twice as common as it was 20 years ago. To understand why, ENDIA (Environmental Determinants of Islet Autoimmunity) Study is the world first trial to follow babies from the pregnancy through childhood to examine early life exposures and the influence these may have on the development of type 1 diabetes.
Eligible family members include mums, dads or older brothers or sisters with type 1 diabetes; babies aged under six months who have a first degree relative with T1DM are also welcome to participate.
Men with type 1 diabetes who are about to become fathers are especially sought after as the genetic risk for their offspring developing islet autoimmunity or type 1 diabetes is slightly higher than other family members.
Pharmacists are asked to be alert to any men presenting with type 1 diabetes who may be eligible.
Referrals across the country are gratefully received by emailing email@example.com or via the website: www.endia.org.au, or calling: Adelaide – (08) 8161 7349; Brisbane – (07) 3163 1759; Geelong – 0478 336 610; Melbourne – (03) 9342 8641; Newcastle – 0408 162 559; Perth – (08) 9340 7974; Sydney – (02) 9832 9243; ALL OTHER AREAS – (08) 8161 8655
ENDIA has a Regional Participation Program for those living in more remote settings to be able to participate from their home.
This study has ethical approval from HRECs across the country and current funding from JDRF Australia and the Helmsley Charitable Trust.